Australasian Journal of Dermatology provides the latest peer-reviewed, original research articles, reviews and case reports dealing with all aspects of clinical practice and research in dermatology.
Moisturisers from birth in at-risk infants of atopic dermatitis: A pragmatic randomised controlled trial
Pamela Si Min Ng, Lynette Wei Yi Wee, Valerie Pui Yoong Ho, Weixuan ColinTan, Priya Bishnoi, Uma Alagappan, Sharon Mun Yee Wong, Emily Yiping Gan, Bin Huey Quek, Liang Shen, Bing Su, John EA Common, Mark Jean Aan Koh
Atopic dermatitis (AD) is a chronic skin condition, often manifesting in early infancy. While several studies have evaluated the early use of moisturising in the prevention of AD, there have been mixed findings. To compare the incidence of moderate or severe AD and total incidence in a cohort of ‘at-risk’ infants of predominantly Asian descent, a pragmatic randomised controlled trial (RCT) was conducted. There were two groups: (1) a treatment group that received moisturisers from the first 2-weeks of life; and (2) a control group that did not receive moisturisers.
No significant differences in incidence of moderate or severe AD, and total incidence of AD at 12 months between the treatment and control groups were observed. Compared to the control group, there was a lower mean SCORAD (severity of disease) in the treatment group, but no significant differences in trans-epidermal water loss (TEWL), stratum corneum (SC) hydration and skin pH between the groups were reported.
Overall, the study found that the early use of moisturisers in ‘at-risk’ infants did not reduce the risk of developing AD.
About the Journal
The Australasian Journal of Dermatology is the official journal of the Australasian College of Dermatologists and the New Zealand Dermatological Society. Editorially independent and peer-reviewed, the journal showcases the latest in dermatology research and innovation.
With four issues a year and special editions, the journal covers clinical presentations, medical and physical therapies and investigations, including dermatopathology, mycology, dermoscopy, surgery and contact dermatitis.
2020 Journal metrics
Accessing the Journal
ACD members have complimentary access to the AJD. Members can access the journal by logging into the Members only section of College’s website and selecting ‘My Online Journals’.
Professor Kiarash Khosrotehrani
Institute of Molecular Bioscience, The University of Queensland Diamantina Institute, Brisbane, Australia.
Associate Professor Helmut Schaider
Dermatology Research Centre, School of Medicine, University of Queensland, Brisbane, Australia.
Professor Khosrotehrani is a clinician-scientist, practicing dermatologist with a focus on delivering state of the art concept and technologies to real-world clinical problems.
A Fellow of the Australasian College of Dermatologists (ACD), he leads the Experimental Dermatology Group at the University of Queensland Diamantina Institute in Brisbane, Australia; is deputy director of the Australian Skin and Skin Cancer Research Centre in Brisbane and practises at the Princess Alexandra Hospital and the Skin and Cancer Foundation’s Queensland Institute of Dermatology.
Passionate about the development of academic medicine and future academic clinicians, he is chair of ACD’s Academic Research Committee, President of the Australasian Society for Dermatology Research and a board member of the International Society for Investigative Dermatology.
He obtained his MD in Paris, France specialising in Dermatology and is a former graduate of the Ecole Normale Supérieure and the Institut Pasteur of Paris (Université Paris VI, Pierre et Marie Curie) obtaining a PhD in Physiology and Physiopathology. He completed his post-doctoral training in stem cell biology and clinical genetics at Tufts-New England Medical Centre in Boston, USA.
Acknowledged by the National Health and Medical Research Council (NHMRC) of Australia through an achievement award (2011) and an NHMRC excellence award (2016), his research is fundamentally based on regenerative medicine concepts applied at basic, translational and clinical levels to melanoma, keratinocyte cancers and skin wounds and takes a multidisciplinary approach. This unique expertise and leadership in research is witnessed by a record of highly cited articles (over 3700 citations, H index 33).
Associate Professor Schaider is an academic dermatologist recognised as a clinical researcher in skin cancer focusing on melanoma biology and early detection of melanoma.
He is a Fellow of the Australasian College of Dermatologists, Treasurer of the Australasian Society of Dermatology Research and is practising at the Sunshine Coast University Hospital and the Princess Alexandra Hospital, Brisbane.
He obtained his medical degree at the Medical University of Graz, Austria, and received training as a postdoctoral researcher in pharmacology at the German Cancer Research Centre, Heidelberg, Germany and melanoma biology at The Wistar Institute, Philadelphia, US.
After relocating to Australia, he set up an independent research group at the Translational Research Institute, Brisbane aiming to identify novel targets tackling cancer drug resistance and improving early detection of melanoma. His group recently identified a chronic stress induced drug tolerant phenotype in cancer and found a novel potential druggable target. Early detection of melanoma is utilizing cutting edge technology like 3D whole body photography to develop surveillance programs for high-risk patients.
|Dr Nikki Adler||Monash University, Melbourne, Australia|
|Dr Keng Chen||Sable Dermatology, Sydney, Australia|
|Dr Peggy Chen||Taranaki District Health Board, New Plymouth, New Zealand|
|Dr Harriet Cheng||Auckland City Hospital, Auckland|
|Dr Karen Cheung||The Skin Hospital, Sydney, Australia|
|Dr Haady Fallah||Concord Repatriation General Hospital, Sydney, Australia|
|Dr Esther Hong||Royal North Shore Hospital of Sydney, Sydney, Australia|
|Dr Joseph Konya||The Skin Hospital, Sydney, Australia|
|Prof Prasad Kumarasinghe||Fiona Stanley Hospital, Perth, Australia|
|A/Prof Christopher McCormack||Peter MacCallum Cancer Centre, Melbourne Australia|
|Dr Anne O’Neill||The Children’s Hospital at Westmead, Sydney Australia|
|Dr David Orchard||Private Suites Royal Children’s Hospital, Melbourne, Australia|
|Dr Yan Pan||Victorian Melanoma Service, Alfred Hospital, VIC, Australia|
|A/Prof Helmut Schaider||Dermatology Research Centre, The University of Queensland Diamantina Institute, Brisbane, Australia|
|A/Prof Stephen Shumack||Royal North Shore Hospital of Sydney, Sydney, Australia|
|Prof Rodney Sinclair||University of Melbourne and Epworth Hospital, Melbourne, Australia|
|Prof H Peter Soyer||Dermatology Research Centre, The University of Queensland Diamantina Institute, Brisbane, Australia|
|Dr Keng-Ee Thai||Royal Australian Army Medical Corps|
|Dr Orli Wargon||Sydney Children’s Hospital, Sydney, Australia|
|Dr Ashfaq Marghoob||Memorial Sloan Kettering Skin Cancer Center, New York, NY, USA|
|Prof John McGrath||St John’s Institute of Dermatology, London, United Kingdom|
|Dr Masaru Tanaka||Tokyo Woman’s Medical University, Medical Center East, Tokyo, Japan|
|Dr Mark Tang||National Skin Centre, Singapore|
|Dr Clark C Otley||Mayo Clinic, Rochester, USA|